Ligand validation:9QAR

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9QAR_NAG_B_701	31%	52%	0.135	0.803	0.52	1.33	-	3	0	0	100%	1
9GBS_NAG_B_816	78%	41%	0.081	0.922	0.58	1.67	-	4	4	0	100%	1
9GBQ_NAG_A_701	76%	55%	0.084	0.918	0.52	1.21	-	2	0	0	100%	1
8QFX_NAG_D_718	66%	49%	0.1	0.904	0.5	1.44	-	2	4	0	100%	0.87
9QAU_NAG_A_703	65%	42%	0.093	0.894	0.63	1.59	-	3	0	0	100%	1
9GBP_NAG_A_707	61%	36%	0.099	0.888	0.64	1.84	-	2	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.